Glucose-lowering therapy after myocardial infarction: more questions than answers

European Heart Journal
Peter W Radke, Heribert Schunkert

Abstract

This editorial refers to The impact of glucose-lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial by L.G. Mellbin et al., on page 166 and Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart by M. Alselmino et al., on page 177

Citations

Apr 30, 2013·The Canadian Journal of Cardiology·Blair J O'NeillLawrence A Leiter
Jan 17, 2020·Circulation. Arrhythmia and Electrophysiology·Thomas PezawasAndré Diedrich

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.